Editors: Atta-ur-Rahman , M. Iqbal Choudhary

Frontiers in CNS Drug Discovery

Volume 1

eBook: US $44 Special Offer (PDF + Printed Copy): US $303
Printed Copy: US $281
Library License: US $176
ISSN: 1879-6656 (Print)
ISSN: 1879-6613 (Online)
ISBN: 978-1-60805-363-6 (Print)
ISBN: 978-1-60805-159-5 (Online)
Year of Publication: 2010
DOI: 10.2174/97816080515951100101


“Frontiers in CNS Drug Discovery” is an eBook series devoted to publishing the latest and the most important advances in Central Nervous System (CNS) drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The eBook series should prove to be of interest to all pharmaceutical scientists involved in research in CNS drug design and discovery. Each volume is devoted to the major advances in CNS drug design and discovery. The eBook series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.

Indexed in: Book Citation Index, Science Edition, Web of Science, BIOSIS Previews, EMBASE, EBSCO.


- Pp. i
Atta-ur-Rahman, M. Iqbal Choudhary
Download Free


- Pp. ii-ix (8)
Bentham Science Publishers
Download Free

Antiretroviral Therapy and HIV-1-Associated Dementia

- Pp. 1-20 (20)
Michela Pollicita, Luigi Ronga, Valentina Svicher, Carlo Federico Perno, Stefano Aquaro
View Abstract

Protective Substances Against Zinc-Induced Neuronal Death after Ischemia: Carnosine as a Target for Drug of Vascular Type of Dem

- Pp. 21-30 (10)
Masahiro Kawahara, Keiko Konoha, Tetsuya Nagata, Yutaka Sadakane
View Abstract

Therapeutical Potentials of Protein Kinase C Activators as Antidementic and Cognition-Enhancing Agents

- Pp. 31-50 (20)
Miao-Kun Sun, Daniel L. Alkon
View Abstract

Insulin-Like Growth Factor-1 and its Derivatives: Potential Pharmaceutical Application for Ischemic Brain Injury

- Pp. 51-75 (25)
Jian Guan
View Abstract

Galantamine, a Natural Product for the Treatment of Alzheimer's Disease

- Pp. 76-105 (30)
Luis Marco, Maria do Carmo Carreiras
View Abstract

Therapeutic Treatment of Alzheimer's Disease Using Metal Complexing Agents

- Pp. 106-122 (17)
Katherine A. Price, Peter J. Crouch, Anthony R. White
View Abstract

Alzheimer's Disease Drug Discovery: Potential Therapeutic Strategies and Future Treatments

- Pp. 123-146 (24)
Laurent Lecanu, Vassilios Papadopoulos
View Abstract

Pharmacological Treatment for Parkinson's Disease: A Continuing Evolution

- Pp. 147-155 (9)
Quincy J. Almeida, H. Christopher Hyson
View Abstract

Vasopressin Antagonists as Anxiolytics and Antidepressants: Recent Developments

- Pp. 156-183 (28)
Karine Fabio, Christophe Guillon, Shi-fang Lu, Ned D. Heindel, Marvin Miller, Craig F. Ferris, Michael J. Brownstein, Carrie Gar
View Abstract

Recent Developments in Anxiety Disorders

- Pp. 184-205 (22)
David M. Christmas, Geetha Menon, Sean D. Hood
View Abstract

Drugs and Aggression†

- Pp. 206-223 (18)
Alberto A. Rasia-Filho, Marcia Giovenardi, Rosa M.M. de Almeida
View Abstract

Antiepileptic Drug and Estradiol Neuroprotection in Epilepsy

- Pp. 224-244 (21)
Libor Velisek, Jana Veliskova
View Abstract

Glucocorticoids Involvement in the Control of CNS Excitability: An Updated

- Pp. 245-283 (39)
Anna Capasso, Mariella Caputo, Mario Felice Tecce, Alberto Loizzo
View Abstract

Glycine Transporter Inhibitors as Therapeutic Agents for Schizophrenia

- Pp. 284-303 (20)
Kenji Hashimoto
View Abstract

Blocking Striatal Adenosine A2A Receptors: A New Strategy for Basal Ganglia Disorders

- Pp. 304-341 (38)
Christa E. Muller, Sergi Ferre
View Abstract

The Astrocytic GABAA/Benzodiazepine-Like Receptor: Identifying the Joker Receptor for Benzodiazepine-Mimetic Drugs?

- Pp. 342-361 (20)
Leif Hertz, Ye Chen
View Abstract

Muscarinic Acetylcholine Receptors as Novel Therapeutic Targets

- Pp. 362-377 (16)
Ada Maria Tata
View Abstract

Tachykinergic System and Binding Molecules in Disease: Implication for Targeted Therapies

- Pp. 378-389 (12)
Pranela Rameshwar
View Abstract

The Gastrin-Releasing Peptide Receptor as a Therapeutic Target in CNS Disorders

- Pp. 390-399 (10)
Rafael Roesler, Flavio Kapczinski, Joao Quevedo, Felipe Dal Pizzol, Gilberto Schwartsmann
View Abstract

GPCR Drug Pipeline: New Compounds for CNS Diseases

- Pp. 400-412 (13)
William K. Lim
View Abstract

Drugs that Act Through Membrane Receptors and Involve an Action of Inverse Agonism

- Pp. 413-429 (17)
Gabriel Barreda-Gomez, Rafael Rodriguez-Puertas
View Abstract

Neurokinin 3 (NK3) Receptor Modulators for the Treatment of Psychiatric Disorders

- Pp. 430-458 (29)
Paul W. Smith, Lee A. Dawson
View Abstract

Functional Interference of Dexamethasone on Some Morphine Effects: Hypothesis for the Steroid-Opioid Interaction: An Updated

- Pp. 459-496 (38)
Anna Capasso, Mariella Caputo, Mario Felice Tecce, Alberto Loizzo
View Abstract

The Quest to Repair the Damaged Spinal Cord

- Pp. 497-518 (22)
Maria Teresa Moreno-Flores, Jesus Avila
View Abstract

The Hypothalamus and Obesity

- Pp. 519-536 (18)
Joanne A. Harrold, Jason C.G. Halford
View Abstract

Therapeutic Approach of Histamine H3 Receptors in Obesity

- Pp. 537-542 (6)
Takayuki Masaki, Hironobu Yoshimatsu
View Abstract

Recent Patents on Pharmacotherapy for Alcoholism

- Pp. 543-599 (57)
Jozsef Nagy
View Abstract

In Search of Novel and Therapeutically Significant Melatoninergic Ligands

- Pp. 600-610 (11)
Sejal M. Mody, Yueqing Hu, Maurice K.C.Ho, Yung H. Wong
View Abstract

Voltage-Gated Sodium Channel Blockers as Immunomodulators

- Pp. 611-624 (14)
Francesco Roselli, Giovanni Defazio, Paolo Livrea, Emilio Jirillo
View Abstract

Global Availability and Utilization of Medication Assisted Treatment of Drug Abuse and Dependence: An Update

- Pp. 625-637 (13)
Thomas F. Kresina, Billy Pick
View Abstract

Author Index to Volume 1

- Pp. 638-639 (2)
Bentham Science Publishers
Download Free


.Biotechnology and Drug Development for Targeting Human Diseases.
.Enzymatic Targets for Drug Discovery Against Alzheimer
.Applied Computer-Aided Drug  Design: Models and Methods.
.Medicinal Plants, Phytomedicines and Traditional Herbal Remedies for Drug Discovery and Development against COVID-19.